Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Heartcore Enterprises Inc
HeartCore Reports Financial Results for Second Quarter and Six Months Ended June 30, 2025
Business
Aug 13 2025
16 min read

HeartCore Reports Financial Results for Second Quarter and Six Months Ended June 30, 2025

news images

NEW YORK and TOKYO, Aug. 13, 2025 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a leading enterprise software and consulting services company based in Tokyo, reported financial results for the second quarter and six months ended June 30, 2025.

Second Quarter 2025 and Recent Operational & Financial Highlights

  • As of June 30, 2025, HeartCore’s total shareholders’ equity totaled $3.5 million. The Company believes that it is now in compliance with the $2.5 million minimum stockholders’ equity requirement set forth in Nasdaq Listing Rule 5550(b) for continued listing on the Nasdaq Capital Market.

  • Partnered with Silver Egg Technology CO., Ltd. to integrate new recommendation engine into its CMS platform.

  • Signed 15th and 16th Go IPO Contract.

  • Announced strategic partnership with NEC Solutions Innovators, Ltd. to enhance CMS implementation process.


Management Commentary

“I am pleased to report a strong second quarter, marked by our return to profitability,” said HeartCore CEO Sumitaka Kanno. “These results reflect the resilience of our software business, which was bolstered by a significant deal with a major infrastructure company that was closed during the quarter. Our second quarter results were particularly encouraging, especially during a period without any Go IPO client listings. We signed our 15th and 16th Go IPO contract wins late in the second quarter and early in the third quarter, but more notably, we expect one of our existing Go IPO clients to successfully list on the Nasdaq Stock Market in the near-term. This is expected to further strengthen our results in the third quarter. In the broader IPO market, there were several other APAC-based companies outside of our pipeline that successfully listed in 2025, which we view as a positive indicator for our Go IPO business. Looking ahead, we are excited to host our Go IPO Korea event next month, which we hope will mark the beginning of a stronger presence in the Korean market. With encouraging signs from the general IPO landscape, we remain focused on expanding our reach to APAC companies seeking to list on U.S. exchanges, while continuing to guide our existing clients throughout the listing process and ultimately, across the finish line as a publicly traded company.”

Second Quarter 2025 Financial Results
Revenues increased by 16.7% to $4.7 million, compared to $4.1 million in the same period last year. The increase was primarily due to (i) the increased sale of on-premise software mainly from multiple large orders of CMS licenses in the second quarter of 2025, compared to the same period last year, (ii) increased software-as-a-service (“SaaS”) revenue due to the Company putting more efforts into expanding and promoting its traditional SaaS business in Japan, and (iii) obtaining more orders, partially offset by (iv) a decrease in customized software development and services revenue in connection with the intense competition of the software market in the U.S., and a decrease in software development and other services, mainly as the Company shifted its business strategies to focus more on development and expansion its on-premise software revenue and SaaS revenue.

Gross profit increased 175.2% to $2.2 million, compared to $0.8 million in the same period last year. The increase was primarily due to (i) an increase in gross profit from sales of on-premise software as the sale increased dramatically while there was not much change in the corresponding costs as the product was developed independently and fixed costs which were not proportional to sales, (ii) an increase in gross profit from customized software development and services as Sigmaways reduced outsourcing costs by ending cooperation with costly vendors, resulting in costs that decreased more dramatically than revenue did, and (iii) an increase in gross profit from the Company’s IPO consulting services.
  
Operating expenses decreased to $2.1 million, compared to $2.3 million in the same period last year. The decrease was primarily due to a decrease in general and administrative expenses.

Net income was $1.1 million, compared to a net loss of $2.2 million in the same period last year, as a result of the aforementioned increases in revenue and gross profit.

Adjusted EBITDA was $0.1 million for the second quarter of 2025, compared to $(1.2) million in the same period last year.

As of June 30, 2025, the Company had cash and cash equivalents of $2.3 million, compared to $2.1 million on December 31, 2024.

Six Months Ended June 30, 2025 Financial Results
Revenues were $8.3 million, compared to $9.1 million in the same period last year. The decrease was primarily due to (i) a decrease in customized software development and services revenue in connection with a slowdown in Sigmaways revenue, driven by intensified competition in the U.S. software market, (ii) decreased Go IPO consulting services revenue mainly due to fewer ongoing IPO consulting projects, (iii) decreased software development and other services revenue mainly as the Company shifted its business strategies to focus more on development and expansion of its on-premise software and SaaS revenue in the second quarter of 2025, resulting in fewer resources and efforts dedicated to software development and other services, partially offset by (iv) an increase in on-premise software revenue due to the Company obtaining several large CMS license orders in the current period.

Gross profit increased 16.9% to $3.3 million, compared to $2.8 million in the same period last year. The increase was primarily due to (i) an increase in gross profit from the sale of on-premise software, as sales rose significantly while related costs remained largely unchanged since the product was independently developed with fixed costs not proportional to sales, and (ii) increased gross profit from customized software development and services, as Sigmaways reduced outsourcing costs by ending cooperation with costly vendors in the current period.

Operating expenses decreased to $4.4 million, compared to $5.0 million in the same period last year. The improvement was primarily due to a decrease in general and administrative expenses.

Net loss improved to $2.1 million, compared to a loss of $3.7 million in the same period last year, as a result of the aforementioned increase in gross profit during the period and increase in revenue in the second quarter.

Adjusted EBITDA was $(1.1) million for the six months ended June 30, 2025, compared to $(1.6) million in the same period last year.

About HeartCore Enterprises, Inc.
Headquartered in Tokyo, Japan, HeartCore Enterprises is a leading enterprise software and consulting services company. HeartCore offers Software as a Service (SaaS) solutions to enterprise customers in Japan and worldwide. The Company also provides data analytics services that allow enterprise businesses to create tailored web experiences for their clients through best-in-class design. HeartCore’s customer experience management platform (CXM Platform) includes marketing, sales, service and content management systems, as well as other tools and integrations, which enable companies to enhance the customer experience and drive engagement. HeartCore also operates a digital transformation business that provides customers with robotics process automation, process mining and task mining to accelerate the digital transformation of enterprises. HeartCore’s GO IPOSM consulting services helps Japanese-based companies go public in the U.S. Additional information about the Company’s products and services is available at and https://heartcore-enterprises.com/.

Non-GAAP Financial Measures Disclaimer
This document includes references to adjusted EBITDA, which is a non-GAAP financial measure. For the purposes of this presentation, adjusted EBITDA is calculated by adjusting net loss to exclude depreciation and amortization, changes in fair value of investments in marketable securities, changes in fair value of investment in warrants, interest income, and interest expenses.

This measure is presented as supplemental information and is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with accounting principles generally accepted in the U.S. (“GAAP”).

Management believes that adjusted EBITDA provides useful information to investors by highlighting the Company’s core operational performance, excluding non-cash and non-recurring items. However, non-GAAP financial measures have limitations and should not be considered in isolation or as a substitute for financial results prepared in accordance with GAAP.

 

For the three months ended June 30,

Item

2025

2024

Net loss

$1.1 million

-$2.2 million

(+) Depreciation and amortization expense

$0.0 million

$0.2 million

(+) Changes in fair value of investments in marketable securities

-$0.9 million

$0.2 million

(+) Changes in fair value of investment in warrants

-$0.1 million

$0.6 million

(-) Interest income

-$0.0 million

-$0.0 million

(+) Interest expenses

$0.0 million

$0.0 million

Adjusted EBITDA

$0.1 million

-$1.2 million

 

 

 


 

For the six months ended June 30,

Item

2025

2024

Net loss

-$2.1 million

-$3.7 million

(+) Depreciation and amortization expense

$0.0 million

$0.4 million

(+) Changes in fair value of investments in marketable securities

$0.9 million

$0.4 million

(+) Changes in fair value of investment in warrants

-$0.1 million

$1.2 million

(-) Interest income

-$0.0 million

-$0.0 million

(+) Interest expenses

$0.1 million

$0.1 million

Adjusted EBITDA

-$1.1 million

-$1.6 million

 

 

 

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, or the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included in this press release are forward-looking statements. In some cases, forward-looking statements can be identified by words such as “believed,” “intend,” “expect,” “anticipate,” “plan,” “potential,” “continue,” or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks, and uncertainties are discussed in HeartCore’s filings with the Securities and Exchange Commission. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond HeartCore’s control which could, and likely will materially affect actual results, and levels of activity, performance, or achievements. Any forward-looking statement reflects HeartCore’s current views with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to operations, results of operations, growth strategy, and liquidity. HeartCore assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The contents of any website referenced in this press release are not incorporated by reference herein.

HeartCore Investor Relations Contact:
Gateway Group, Inc.
Matt Glover and John Yi
HTCR@gateway-grp.com
(949) 574-3860

 

 

 

 

 

 

HeartCore Enterprises, Inc.

 

Consolidated Balance Sheets

 

 

 

 

 

 

 

 

 

June 30,

 

December 31,

 

 

 

2025

 

2024

 

 

 

(Unaudited)

 

 

 

ASSETS

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

$

2,347,622

 

$

2,121,089

 

 

Accounts receivable

 

3,000,337

 

 

1,950,050

 

 

Investments in marketable securities

 

2,495,016

 

 

4,495,703

 

 

Prepaid expenses

 

503,171

 

 

458,839

 

 

Current portion of long-term note receivable

 

100,000

 

 

100,000

 

 

Due from related party

 

44,148

 

 

40,139

 

 

Deferred offering costs

 

250,000

 

 

-

 

 

Other current assets

 

186,944

 

 

251,545

 

 

Total current assets

 

8,927,238

 

 

9,417,365

 

 

 

 

 

 

 

 

Non-current assets:

 

 

 

 

 

Accounts receivable, non-current

 

1,058,539

 

 

752,930

 

 

Property and equipment, net

 

442,475

 

 

584,854

 

 

Operating lease right-of-use assets

 

1,853,466

 

 

1,936,097

 

 

Long-term investment in warrants

 

650,446

 

 

577,786

 

 

Long-term note receivable

 

100,000

 

 

100,000

 

 

Deferred tax assets

 

138,263

 

 

152,300

 

 

Security deposits

 

225,649

 

 

307,996

 

 

Long-term loan receivable from related party

 

114,230

 

 

123,928

 

 

Other non-current assets

 

15,014

 

 

11,778

 

 

Total non-current assets

 

4,598,082

 

 

4,547,669

 

 

 

 

 

 

 

 

Total assets

$

13,525,320

 

$

13,965,034

 

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS' EQUITY

 

Current liabilities:

 

 

 

 

 

Accounts payable and accrued expenses

$

1,758,084

 

$

2,039,323

 

 

Accounts payable and accrued expenses - related party

 

22,924

 

 

47,199

 

 

Accrued payroll and other employee costs

 

752,787

 

 

675,502

 

 

Due to related parties

 

590

 

 

932

 

 

Short-term debt - related party

 

75,000

 

 

75,000

 

 

Current portion of long-term debts

 

382,494

 

 

401,255

 

 

Insurance premium financing

 

90,869

 

 

16,626

 

 

Factoring liability

 

226,212

 

 

172,394

 

 

Operating lease liabilities, current

 

290,886

 

 

371,951

 

 

Finance lease liabilities, current

 

17,666

 

 

15,956

 

 

Income tax payables

 

716,263

 

 

822,014

 

 

Deferred revenue

 

1,702,068

 

 

1,876,490

 

 

Derivative liability

 

236,141

 

 

-

 

 

Other current liabilities

 

821,858

 

 

907,080

 

 

Total current liabilities

 

7,093,842

 

 

7,421,722

 

 

 

 

 

 

 

 

Non-current liabilities:

 

 

 

 

 

Long-term debts

 

1,097,263

 

 

1,238,813

 

 

Operating lease liabilities, non-current

 

1,613,378

 

 

1,614,996

 

 

Finance lease liabilities, non-current

 

39,085

 

 

43,593

 

 

Asset retirement obligations

 

122,735

 

 

183,895

 

 

Total non-current liabilities

 

2,872,461

 

 

3,081,297

 

 

 

 

 

 

 

 

Total liabilities

 

9,966,303

 

 

10,503,019

 

 

 

 

 

 

 

 

Shareholders' equity:

 

 

 

 

 

Preferred shares, $0.0001 par value, 20,000,000 shares authorized; Series A convertible preferred shares, 2,000 and no shares designated, issued and outstanding as of June 30, 2025 and December 31, 2024, respectively; aggregate liquidation preference of $2,200,611 and nil as of June 30, 2025 and December 31, 2024, respectively

 

-

 

 

-

 

 

Common shares, $0.0001 par value, 200,000,000 shares authorized, 23,310,770 and 21,937,987 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively

 

2,331

 

 

2,193

 

 

Subscription receivable

 

-

 

 

(103,942

)

 

Additional paid-in capital

 

22,676,912

 

 

20,656,153

 

 

Accumulated deficit

 

(18,231,933

)

 

(16,244,843

)

 

Accumulated other comprehensive income

 

393,124

 

 

343,936

 

 

Total HeartCore Enterprises, Inc. shareholders' equity

 

4,840,434

 

 

4,653,497

 

 

Non-controlling interests

 

(1,281,417

)

 

(1,191,482

)

 

Total shareholders' equity

 

3,559,017

 

 

3,462,015

 

 

 

 

 

 

 

 

Total liabilities and shareholders' equity

$

13,525,320

 

$

13,965,034

 

 

 

 

 

 

 

 



HeartCore Enterprises, Inc.

 

Unaudited Consolidated Statements of Operations and Comprehensive Income (Loss)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the six months ended June 30,

 

 

 

2025

 

 

 

2024

 

 

 

 

 

 

 

 

 

Revenues

$

8,331,272

 

 

$

9,113,120

 

 

Cost of revenues

 

5,013,393

 

 

 

6,275,050

 

 

Gross profit

 

3,317,879

 

 

 

2,838,070

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

Selling expenses

 

676,782

 

 

 

399,115

 

 

General and administrative expenses

 

3,492,415

 

 

 

4,428,712

 

 

Research and development expenses

 

285,374

 

 

 

200,402

 

 

Total operating expenses

 

4,454,571

 

 

 

5,028,229

 

 

 

 

 

 

 

 

 

Income (loss) from operations

 

(1,136,692

)

 

 

(2,190,159

)

 

 

 

 

 

 

 

 

Other income (expenses):

 

 

 

 

 

 

Changes in fair value of investments in marketable securities

 

(928,955

)

 

 

(430,331

)

 

Changes in fair value of investment in warrants

 

72,660

 

 

 

(1,237,707

)

 

Interest income

 

4,861

 

 

 

4,624

 

 

Interest expenses

 

(61,798

)

 

 

(73,701

)

 

Other income

 

56,920

 

 

 

134,874

 

 

Other expenses

 

(29,797

)

 

 

(49,050

)

 

Total other income (expenses)

 

(886,109

)

 

 

(1,651,291

)

 

 

 

 

 

 

 

 

Income (loss) before income tax expense (benefit)

 

(2,022,801

)

 

 

(3,841,450

)

 

 

 

 

 

 

 

 

Income tax expense (benefit)

 

53,074

 

 

 

(152,330

)

 

 

 

 

 

 

 

 

Net income (loss)

 

(2,075,875

)

 

 

(3,689,120

)

 

Less: net loss attributable to non-controlling interests

 

(88,785

)

 

 

(404,670

)

 

Net income (loss) attributable to HeartCore Enterprises, Inc.

 

(1,987,090

)

 

 

(3,284,450

)

 

Dividends accrued on Series A convertible preferred shares

 

(611

)

 

 

-

 

 

Net income (loss) attributable to HeartCore Enterprises, Inc. common shareholders

$

(1,987,701

)

 

$

(3,284,450

)

 

 

 

 

 

 

 

 

Other comprehensive income (loss):

 

 

 

 

 

 

Foreign currency translation adjustment

 

48,038

 

 

 

(13,825

)

 

 

 

 

 

 

 

 

Total comprehensive income (loss)

 

(2,027,837

)

 

 

(3,702,945

)

 

Less: comprehensive loss attributable to non-controlling interests

 

(89,935

)

 

 

(412,471

)

 

Comprehensive income (loss) attributable to HeartCore Enterprises, Inc.

$

(1,937,902

)

 

$

(3,290,474

)

 

 

 

 

 

 

 

 

Net income (loss) per common share attributable to HeartCore Enterprises, Inc.

 

 

 

 

Basic

$

(0.09

)

 

$

(0.16

)

 

Diluted

$

(0.09

)

 

$

(0.16

)

 

 

 

 

 

 

 

 

Weighted average common shares outstanding

 

 

 

 

 

 

Basic

 

22,072,324

 

 

 

20,859,429

 

 

Diluted

 

22,072,324

 

 

 

20,859,429

 

 



HeartCore Enterprises, Inc.

 

Unaudited Consolidated Statements of Cash Flows

 

 

 

 

 

 

 

 

 

For the six months ended June 30,

 

 

 

2025

 

 

2024

 

 

 

 

 

 

 

 

Cash flows from operating activities:

 

 

 

 

 

Net loss

$

(2,075,875

)

$

(3,689,120

)

 

Adjustments to reconcile net loss to net cash flows

 

 

 

 

 

used in operating activities:

 

 

 

 

 

Depreciation and amortization expenses

 

42,437

 

 

374,946

 

 

Loss on disposal of property and equipment

 

117,305

 

 

1,894

 

 

Amortization of debt issuance costs

 

2,194

 

 

2,296

 

 

Non-cash lease expense

 

163,354

 

 

182,546

 

 

Gain on termination of lease

 

(9,059

)

 

(469

)

 

Deferred income taxes

 

28,008

 

 

(153,531

)

 

Stock-based compensation

 

60,204

 

 

147,754

 

 

Changes in fair value of investments in marketable securities

 

928,955

 

 

430,331

 

 

Changes in fair value of investment in warrants

 

(72,660

)

 

1,237,707

 

 

Gain on settlement of asset retirement obligations

 

(45,873

)

 

-

 

 

Changes in assets and liabilities:

 

 

 

 

 

Accounts receivable

 

(1,145,166

)

 

(823,402

)

 

Prepaid expenses

 

126,001

 

 

158,110

 

 

Other assets

 

182,063

 

 

(7,526

)

 

Accounts payable and accrued expenses

 

(320,566

)

 

272,375

 

 

Accounts payable and accrued expenses - related party

 

(23,386

)

 

21,956

 

 

Accrued payroll and other employee costs

 

31,589

 

 

(278,361

)

 

Due to related parties

 

(370

)

 

(1,246

)

 

Operating lease liabilities

 

(159,030

)

 

(183,047

)

 

Income tax payables

 

(108,943

)

 

(152,697

)

 

Deferred revenue

 

(282,704

)

 

165,073

 

 

Other liabilities

 

(113,370

)

 

558,667

 

 

Net cash flows used in operating activities

 

(2,674,892

)

 

(1,735,744

)

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

Purchases of property and equipment

 

(1,235

)

 

(4,134

)

 

Prepayment for property and equipment

 

-

 

 

(35,209

)

 

Purchase of investment in SAFE

 

-

 

 

(75,000

)

 

Net proceeds from sale of warrants

 

-

 

 

5,640,000

 

 

Proceeds from sale of marketable securities

 

1,071,732

 

 

-

 

 

Repayment of loan provided to related party

 

21,139

 

 

21,166

 

 

Net cash flows provided by investing activities

 

1,091,636

 

 

5,546,823

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

Payments for finance leases

 

(8,375

)

 

(8,526

)

 

Proceeds from short-term debt

 

134,689

 

 

68,138

 

 

Repayment of short-term and long-term debts

 

(395,495

)

 

(281,451

)

 

Repayment of insurance premium financing

 

(65,257

)

 

(60,201

)

 

Net proceeds from factoring arrangement

 

53,818

 

 

-

 

 

Net repayment of factoring arrangement

 

-

 

 

(242,008

)

 

Capital contribution from non-controlling shareholder

 

-

 

 

67,195

 

 

Distribution of dividends

 

-

 

 

(417,283

)

 

Proceeds from issuance of common shares

 

30,445

 

 

-

 

 

Proceeds from collection of subscription receivable

 

103,942

 

 

-

 

 

Proceeds from exercise of stock options

 

117,000

 

 

-

 

 

Proceeds from issuance of Series A convertible preferred shares and common shares related to securities purchase agreement, net of share issuance costs

 

1,800,000

 

 

-

 

 

Net cash flows provided by (used in) financing activities

 

1,770,767

 

 

(874,136

)

 

 

 

 

 

 

 

Effect of exchange rate changes

 

39,022

 

 

(143,073

)

 

 

 

 

 

 

 

Net change in cash and cash equivalents

 

226,533

 

 

2,793,870

 

 

 

 

 

 

 

 

Cash and cash equivalents - beginning of the period

 

2,121,089

 

 

1,012,479

 

 

 

 

 

 

 

 

Cash and cash equivalents - end of the period

$

2,347,622

 

$

3,806,349

 

 

 

 

-

 

 

 

 

Supplemental cash flow disclosures:

 

 

 

 

 

Interest paid

$

63,320

 

$

74,063

 

 

Income taxes paid

$

131,118

 

$

117,524

 

 

 

 

 

 

 

 

Non-cash investing and financing transactions:

 

 

 

 

 

Operating lease right-of-use assets obtained in exchange for operating lease liabilities

$

23,495

 

$

125,735

 

 

Insurance premium financing

$

139,500

 

$

172,689

 

 

Warrants converted to marketable securities

$

-

 

$

223,481

 

 

Issuance of common shares related to equity purchase agreement

$

250,000

 

$

-

 

 

Dividends accrued on Series A convertible preferred shares

$

611

 

$

-